Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry de Traux de Wardin

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Genes, Chromosomes & Cancer|April 12, 2024
FGFR1 fusions as a novel molecular driver in rhabdomyosarcomaHenry de Traux De Wardin, Joanna Cyrta, Josephine K Dermawan, et al.
JCO Precision Oncology|June 14, 2023
Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk StratificationHenry de Traux de Wardin, Bin Xu, Josephine K Dermawan, et al.
JCO Precision Oncology|April 11, 2024
<i>NF1</i>-Driven Rhabdomyosarcoma Phenotypes: A Comparative Clinical and Molecular Study of <i>NF1</i>-Mutant Rhabdomyosarcoma and <i>NF1</i>-Associated Malignant Triton TumorHenry de Traux de Wardin, Josephine K Dermawan, Fabio Vanoli, et al.
Oncogenesis|February 21, 2023
Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapyFabio Vanoli, Laurie Herviou, Yusuke Tsuda, et al.
JCO Precision Oncology|June 17, 2024
Modeling Extraordinary Response Through Targeting Secondary Alterations in Fusion-Associated SarcomaFabio Vanoli, Evan Song, Josephine K Dermawan, et al.
NPJ Precision Oncology|September 20, 2023
Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapseHenry de Traux de Wardin, Josephine K Dermawan, Marie-Sophie Merlin, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Genes, Chromosomes & Cancer|April 12, 2024
FGFR1 fusions as a novel molecular driver in rhabdomyosarcomaHenry de Traux De Wardin, Joanna Cyrta, Josephine K Dermawan, et al.
JCO Precision Oncology|June 14, 2023
Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk StratificationHenry de Traux de Wardin, Bin Xu, Josephine K Dermawan, et al.
JCO Precision Oncology|April 11, 2024
<i>NF1</i>-Driven Rhabdomyosarcoma Phenotypes: A Comparative Clinical and Molecular Study of <i>NF1</i>-Mutant Rhabdomyosarcoma and <i>NF1</i>-Associated Malignant Triton TumorHenry de Traux de Wardin, Josephine K Dermawan, Fabio Vanoli, et al.
Oncogenesis|February 21, 2023
Generating in vitro models of NTRK-fusion mesenchymal neoplasia as tools for investigating kinase oncogenic activation and response to targeted therapyFabio Vanoli, Laurie Herviou, Yusuke Tsuda, et al.
JCO Precision Oncology|June 17, 2024
Modeling Extraordinary Response Through Targeting Secondary Alterations in Fusion-Associated SarcomaFabio Vanoli, Evan Song, Josephine K Dermawan, et al.
NPJ Precision Oncology|September 20, 2023
Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapseHenry de Traux de Wardin, Josephine K Dermawan, Marie-Sophie Merlin, et al.
Pageof 1